| INTRODUCTION
Subvalvular aortic stenosis (SAS) is the second most common type of aortic stenosis, accounting for 14% of left ventricular outflow tract (LVOT) obstruction, with valvular aortic stenosis being the most common cause (70%). 1 The prevalence of SAS is 6.5% of all the adult congenital heart diseases. 2 It predominantly involves males, with a maleto-female ratio of 2:1. SAS is associated with defects such as VSD, AVSD, or conotruncal anomalies in 60% of cases and may develop after patch closure of a perimembranous or malaligned VSD or AVSD. 3, 4 SAS is considered an acquired disease. It is rarely diagnosed during infancy, but it often manifests in the first decade of life with features of progressive LVOT obstruction, left ventricular hypertrophy (LVH), and aortic regurgitation (AR). 5 A familial form of this disease, Shone syndrome, has also been described. 6 
| ANATOMY AND PATHOPHYSIOLOGY
SAS encompasses a variety of anatomic lesions that can occur either alone or in combination. The following discrete entities have been described in literature 7, 8 ( Figure 1 ):
1. Thin, crescent-shaped membrane just below the aortic valve: discrete SAS. This represents 75% to 85% of SAS cases.
2. Thick fibromuscular ridge.
3. Tunnel or tubular: long, narrow, fibromuscular channel along the LVOT.
Rarely, abnormal mitral valve chords can cause outflow tract obstruction mimicking SAS. 7 SAS caused by a thin fibrous membrane is more focal. 9 In contrast, a fibromuscular ridge causes more diffuse obstruction and often results in a tunnel-type lesion that is associated with a greater degree of stenosis. Additionally, SAS due to a misaligned VSD with posterior deviation of the outlet septum into the LVOT has been described in literature. 10 This is usually in association with coarctation or interruption of the aortic arch. 10 
| Possible theories explaining development of anatomic lesions
In 1979, Rosenquist et al 11 described 22 heart specimens with SAS and found out that the mean mitral aortic separation in patients with SAS was more than twice that in normal hearts. Based on this particular finding, they speculated that an increase in mitral aortic separation could contribute to the etiology of SAS if this alters the angle at which blood is ejected from the left ventricle during a critical period of early heart development. This, in turn, could cause the embryonic cells near the crest of the ventricular septum to accumulate and eventually differentiate into a ridge or band of fibroelastic tissue.
Another explanation for it to be considered as an acquired lesion is that it is associated with abnormalities in the LVOT and also requires some preexistent morphologic substrate for development. 4 Sigfússon et al. have demonstrated that steepened aortoseptal angle may be a risk factor for the development of SAS (see Supporting Information, Figure 1 , in the online version of this article). Fluid modeling studies have shown that the steepened angle results in altered shear forces. 12 Altered fluid shear stress has been shown to induce vascular endothelial-cell turnover in vitro and has been connected to the development of vascular obstruction in animal models. 13 There is a possible genetic component that has yet to be fully understood. Additionally, there is a possible association with other congenital cardiac defects, as prevalence of congenital cardiac defects has been reported to be as high as 6.5% in adult patients with SAS. 2 
| Progression and hemodynamics
The progressive nature of LVOT obstruction caused by SAS in children has been well documented in literature. 3, 14, 15 However, discrete SAS progresses slowly in adulthood. In particular, patients with associated coronary heart disease are at risk for faster progression and should be monitored closely. 16 Oliver et al., 2 in their analysis of 134 adults diagnosed with SAS, found that the gradient across LVOT measured by Doppler echocardiography increased from a mean of 39 mmHg to 46 mmHg over an average follow-up of 4.8 years.
Factors associated with rate of progression of LVOT obstruction are not completely clear. It is thought that abnormal fluid dynamic forces at the LVOT level can cause septal shear stress, causing cellular growth factors to engineer regional cellular proliferation contributing to the worsening of LVOT obstruction. 4, 12 Why the rate of progression is different in children compared with adults is not completely understood at this time. Perhaps, the earlier in life the septal shear stress is increased above a threshold, the more intense the response and the more rapid the progression of the LVOT obstruction.
The primary hemodynamic effect on the left ventricle is increased afterload. The ventricle hypertrophies in an attempt to reduce wall stress. Also, SAS is associated with AR in 30% to 80% of the patients due to damage of the leaflets from high-velocity jets caused by the stenosis. Others may develop palpitations; rarely, it can lead to congestive heart failure. The diagnosis of SAS starts with the auscultation of a systolic ejection murmur, which is loudest at the left mid-sternal border radiating to the upper sternal border. 18 This leads to the suspicion for the presence of LVOT obstruction. The differential diagnosis of such a murmur includes aortic stenosis, supravalvular aortic stenosis, SAS, and hypertrophic obstructive cardiomyopathy (HOCM).
More detailed physical examination can help to distinguish subaortic stenosis from the other causes of LVOT obstruction, as highlighted in Table 1 . A concurrent diastolic murmur may indicate the presence of AR that can be associated with SAS. Cardiac magnetic resonance imaging (CMR) and cardiac computed tomography (see Supporting Information, Figure 2 , in the online version of this article) 18, 22 are the up-and-coming imaging modalities being used to diagnose different etiologies of LVOT. CMR can be used to clarify anatomy and quantify flow velocity. This can be done using T1-weighted images with 3-to 5-mm slice thickness; but the images are usually inferior to those of transesophageal echocardiography. 23 Another limitation of CMR is that the spin dephasing artifact usually obscures the area of interest. This, along with the fact that the SAS membrane is often thin, makes it difficult to visualize.
Cardiac computed tomography, on the other hand, is typically used in a role that complements transthoracic echocardiography. 22 To date, it has not replaced echocardiography in standard practice because of its limitations: it is more complicated, more expensive, and exposes patients to radiation and iodinated contrast. 22 
| PROGNOSIS
Survival after SAS surgery has been shown to be excellent ( Figure 2A) . However, the LVOT gradient still increases slowly over time. In most patients, follow-up can be done at 2-to 4-year intervals due to the slow nature of the progression of the LVOT obstruction. 24 Two groups that have been found to have a higher rate of progression are females ( Figure 2B ) and patients age > 30 years at time of diagnosis; thus, these patient groups should be monitored more frequently, but there is no set time for echocardiography follow-up intervals. 24 Eventually, most patients will require reoperation for recurrent SAS at some point in their lifetime. 24 Reoperation for recurrent discrete subaortic stenosis is common; the reoperation rate is reported between 6% and 30%. 25 Most of the reports discussing the risk of reoperation in patients undergoing relief of subaortic obstruction have focused on anatomic subtypes. 26 Two high-risk subgroups for recurrence and reoperation were clearly identified: first was the group of patients with tunnel SAS, and the other was the group with multilevel LVOT obstruction. 27 It was suggested that patients with a residual left ventriculo-aortic gradient >30 mmHg at the end of bypass should undergo reoperation with a more aggressive subaortic resection during the same operating session. 25 Table 2 highlights the predictors of reoperation.
The risk of reoperation may be due to inadequate resection at the first operation, yet recurrent obstruction may appear despite the adequacy of surgical excision. 28 One theory suggests that there is a dynamic component that may play a role in residual obstructive LVOT stenosis despite adequate resection. 29 This occurs from regrowth of the tissue from the region of the septum to the initial fibromuscular obstruction. 30 Another theory suggests that the formation of scar tissue in the subvalvular area during the healing process leads to a fixed size of the LVOT, resulting in localized hypertrophy and fibrosis of the LVOT. 31 This may trigger fibromuscular recurrence even though initially it was a discrete membrane. 25 Myectomy is another intervention that can be done to help alleviate LVOT obstruction in SAS. However, even after undergoing myectomy, there is still a high chance of recurrence, with reoperation rates between 10% and 20% within 10 years. 25 In addition, myectomy is associated with an increased risk of complete heart block.
Therefore, given the combination of no long-term benefit and the risk of heart block, myectomy should not be performed routinely, and it only should be performed if marked LVH is present. 24 AR was found in >50% of patients with SAS, but only 20% are considered to be hemodynamically significant. 2 If present, the degree of AR can progress in patients who did not have any repair procedure for SAS. Studies have shown that there is a direct relationship between the severity of SAS and AR. 32 But it has been shown that there is no significant progression of AR. A study by van der Linde et al. showed that in most patients, AR did not progress over time. 24 They also found that 10% of patients who did not have AR before surgery developed mild aortic insufficiency relatively immediately in the postoperative period. Another 10% of patients progressed from mild to moderate AR, and progression to severe AR was found to be very rare ( Figure 3 ). An LVOT gradient ≥80 mmHg was found to be a significant risk factor for developing AR postoperatively (see Support- ing Information, Figure 3 , in the online version of this article).
Hence, it is recommended to operate before the LVOT gradient reaches 80 mmHg. 24 Furthermore, given the possible recurrence and the presence of mild AR, lifelong regular follow-up with echocardiography is required. 24 For a summary of long-term outcomes after an SAS operation, see Supporting Information, Table 1 , in the online version of this article.
| TREATMENT
Definitive therapy for SAS consists of surgical correction of the obstruction, which may involve simple membrane removal, extensive ring resection with or without myectomy, or a Konno procedure. promising results. 35 In the study by Suri et al., there was a postoperative decline, but ejection fraction stabilized with time after the Konno procedure on the follow-up echocardiograms. 37 Sharma et al. demonstrated that the recovery of ventricular function after the Konno procedure is similar to that seen after aortic valve replacement alone, in contrast to initial studies. 38 Pulmonary valve regurgitation can occur as a complication of this procedure and may require pulmonary valve replacement in a minority of patients. In the long-term follow-up of the patients who underwent the procedure, New York
Heart Association status remained class 1 after initial improvement.
Mean follow-up period was 8.2 AE 5.7 years. 37 IE prophylaxis before dental procedures is not recommended as per the 2008 ACC/AHA guidelines unless the patient had prior history of IE or repair with patch or residual defect. IE prophylaxis is recommended only in the initial 6 months after patch repair. 34 6 | CONCLUSION SAS is the second most common type of aortic stenosis, accounting for 6.5% of adult congenital disease. It is considered an acquired disease, with different rates of progression among adults and children.
Most adult patients with SAS are asymptomatic. Symptoms may include pre-syncope, shortness of breath, or fatigue with physical stress, such as exercise or pregnancy. Surgical correction is the treatment of choice, and the prognosis is usually excellent, with varied recurrence rates depending on the presence of certain risk factors.
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